| 1 |
(Kuan-Jung Lin)、(Jui-Ming Liu)、林香汶(Hsiang-Wen Lin)、(Jing-Ru Weng)、(Eman M. E. Dokla)、呂夢恬、朱伯振(Chu, Po-Chen)*，Activation of the Hippo Pathway by ATN Suppresses Cancer Stem-Like Properties and EGFR-Associated Signaling in Castration-Resistant Prostate Cancer Cells in vitro，International Journal of Medical Sciences，2026 May，23(6):2039-2053，SCI |
| 2 |
林志學(Chih-Hsueh Lin)、蔡馨慧(Hsin-Hui Tsai)*、杜俊緯(DU JUN-WEI)、(Shelly L. Gray)、林香汶(Hsiang-Wen Lin)*，Screening criteria of potentially inappropriate medications and associations of exposure timing with incident hospital admissions among older adults in a rural community hospital，BMC Geriatrics，2025 Oct，():，SCI |
| 3 |
林香汶(Hsiang-Wen Lin)、林天照(Tien-Chao Lin)、許茜甯(Chien-Ning Hsu)、葉子裴(Tzu-Pei Yeh)、陳育傑(Jack Yu-Chieh Chen)、劉良智(Liang-Chih Liu)、林振源(Chen-Yuan,Lin)*，Risk prediction of QTc prolongation occurrence in cancer patients treated with commonly used oral tyrosine kinase inhibitors: machine learning modeling or conventional statistical analysis better?，BMC Medical Informatics and Decision Making，2025 Aug，25(1):xx-xx，SCI |
| 4 |
林聖興(Sheng-Shing Lin)、蔡馨慧(Hsin-Hui Tsai)、蔡相德(Daniel Hsiang-Te Tsai)、蔡邱轔(Chiu-Lin Tsai)、(Nanae Itokazu)、林昭庚(Jaung-Geng Lin)、賴嘉鎮(Edward Chia-Cheng Lai)、林香汶(Hsiang-Wen Lin)*、侯毓昌(Yu-Chang Hou)*，Prescription patterns of traditional Chinese medications and potential consequences in patients with new-onset cardiac or vascular-related diseases: a nationwide cohort study，BMC Complementary Medicine and Therapies，2025 Jul，25(216):，SCI |
| 5 |
黃彥銘(Yen-Ming Huang)、(Tzu Wang)、(Yu-Meng Yang)、(Yung-Hsuan Chang)、(Hsun-Yu Chan)*、林香汶(Hsiang-Wen Lin)*，Medication refills do not guarantee medication intake: translation and validation of the Adherence to Refills and Medications Scale in Traditional Chinese among individuals with type 2 diabetes in Taiwan，POSTGRADUATE MEDICINE，2025 Jan，137(1):68-78，SCI |
| 6 |
張人予(Jen-Yu Amy Chang)、許茜甯(Chien-Ning Hsu)、(Juan Manuel Ramos-Goni)、(Nan Luo)、林香汶(Hsiang-Wen Lin)*、林芳如(Fang-Ju Lin)*，Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication，European Journal of Health Economics，2024 Aug，25(6):1041-1055，SSCI |
| 7 |
徐菀翎(Wan-Ling Hsu)、陳珈汶(CHEN, CHIA-WEN)、梁馨樺(Liang, Hsin-Hua)、江岱玲(CHIANG, TAI-LING)、林香汶(Hsiang-Wen Lin)、林宜慧(YI-HUI LIN)*，Innovative analysis of diazepam, zolpidem and their main metabolites in human urine by micelle-to-solvent stacking in capillary electrophoresis，Journal of Pharmaceutical and Biomedical Analysis，2024 Feb，239():1-10，SCI |
| 8 |
蘇孟夏(Meng-Xia Su)、林香汶(Hsiang-Wen Lin)、(Hanh T H Nguyen)、林天照(Tien-Chao Lin)、陳芝蓉(Chih-Jung Chen)、王惠暢(Hwei-Chung Wang)、吳建廷(Chen-Teng Wu)、吳曜充(Yao-Chung Wu)、何庚諺(HE GENG-YAN)、劉良智(Liang-Chih Liu)*、黃至豪(Huang ChihHao)*，Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin，BMC CANCER，2024 Feb，24(1):195，SCI |
| 9 |
蔡佳宏(Chia-Hung Tsai)、黃慧琪(Hui-Chi Huang)、林冠榮(Kuan-Jung Lin)*、柳瑞明(Jui-Ming Liu)、陳冠霖(Guan-Lin Chen)、葉宜嫻(Yi-Hsien Yeh)、陸德齡(TE-LING LU)、林香汶(Hsiang-Wen Lin)、呂夢恬、朱伯振(Chu, Po-Chen)*，Inhibition of Autophagy Aggravates Arachis hypogaea L. Skin Extracts-Induced Apoptosis in Cancer Cells，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES，2024 Jan，25(2):1-18，SCI |
| 10 |
吳坤璋(Wu, Kun-Chang)、林香汶(Hsiang-Wen Lin)、朱伯振(Chu, Po-Chen)、李佳霙(Chia-Ing Li)、高湘涵(Hsiang-Han Kao)、林志學(Chih-Hsueh Lin)、鄭宇容(Cheng, Yu-Jung)*，A non-invasive mouse model that recapitulates disuse-induced muscle atrophy in immobilized patients，Scientific Reports，2023 Dec，13():22201，SCI |
| 11 |
李培志(Lee, Pei-Chih)、(Vathan Kumar)、(Govindan Sivakumar)、曾子育、李易撰(Li, Yi-Chuan)、江禹權(Jiang, Yu-Cyuan)、蕭宇君(Hsiao, Yu-Chun)、林香汶(Hsiang-Wen Lin)*、張誌祥(Chih-Shiang Chang)*、洪明奇(Mien-Chie Hung)*，Development of triazole-based PKC-inhibitors to overcome resistance to EGFR inhibitors in EGFR-mutant lung cancers，American Journal of Cancer Research，2023 Oct，13(10):4693-4707，SCI |
| 12 |
王人杰、蔡馨慧、邱建強、游佩雯、黃彥銘、張雅惠、吳建遠、鍾遠芳、廖宏恩、林香汶(Hsiang-Wen Lin)*，建構健康促進友善社區藥局:藥師和顧客的觀點，台灣公共衛生雜誌/Taiwan Journal of Public Health，2023 Oct，42(5):519-529，TSSCI |
| 13 |
許茜甯(Chien Ning Hsu)、(You-Lin Tain)、(Pei-Chen Lu)、林香汶(Hsiang-Wen Lin)*，Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses，Health and Quality of Life Outcomes，2023 Oct，21(1):1-13，SSCI |
| 14 |
(Daniel Hsiang-Te Tsai)、(Wei-Hung Chang)、林香汶(Hsiang-Wen Lin)、(Swu-Jane Lin)、(Shih-Chieh Shao)、(Edward Chia-Cheng Lai)*，Post-discharge use of antipsychotics in patients with hospital-acquired delirium and associated risk of mortality – A population-based nested case-control study，Asian Journal of Psychiatry，2023 May，83():，SCI |
| 15 |
(Meixia Liao)、(Kim Rand)、(Zhihao Yang)、許茜甯(Chien Ning Hsu)、林香汶(Hsiang-Wen Lin)*、(Nan Luo)*，Censoring in the time trade-off valuation of worse-than-dead EQ-5D-5L health states: can a time-based willingness-to-accept question be the solution?，QUALITY OF LIFE RESEARCH，2023 Apr，32(4):1165-1174，SSCI |
| 16 |
林香汶(Hsiang-Wen Lin)、林振源(Chen-Yuan,Lin)、葉子裴(Tzu-Pei Yeh)、林天照(Tien-Chao Lin)、葉婉真(Wan-Chen Yeh)、楊琳鈞(YANG LIN-JUN)、陳育傑(Jack Yu-Chieh Chen)、邱麗螢(Li-Ying Chiu)、吳建廷(Chen-Teng Wu)、陳芝蓉(Chih-Jung Chen)、陳玉芬(Yu-Fen Chen)、王惠暢(Hwei-Chung Wang)、吳曜充(Yao-Chung Wu)、劉良智(Liang-Chih Liu)*，Quality of care in the course of subcutaneous versus intravenous trastuzumab administration in patients with breast cancer: an integrated time-motion study with mixed-methods research，BMJ Open，2023 Mar，13(3):1-11，SCI |
| 17 |
Okti Ratna Mafruhah(Okti Ratna Mafruhah)、黃彥銘(Yen-Ming Huang)*、林香汶(Hsiang-Wen Lin)*，Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis，JOURNAL OF NEUROLOGY，2023 Feb，():，SCI |
| 18 |
陳芝蓉(Chih-Jung Chen)、Nguyen Thi Hong Hanh(Nguyen Thi Hong Hanh)、黃至豪(Huang ChihHao)、王惠暢(Hwei-Chung Wang)、吳建廷(Chen-Teng Wu)、吳曜充(Yao-Chung Wu)、何庚諺(HE GENG-YAN)、(Chiahung Chou)、林香汶(Hsiang-Wen Lin)*、劉良智(Liang-Chih Liu)*，Does the Timing of Eribulin Treatment for Advanced or Metastatic Breast Cancer Matter? Evidence from a Real-World Setting，CHEMOTHERAPY，2023 Jan，68(1):23-34，SCI |
| 19 |
(Tsai, Chia-Hung)、(Weng, Jing-Ru)、林香汶(Hsiang-Wen Lin)、呂夢恬、劉育綺(Liu, Yu-Chi)、朱伯振(Chu, Po-Chen)*，Targeting Triple Negative Breast Cancer Stem Cells by Heat Shock Protein 70 Inhibitors，Cancers，2022 Oct，14(19):4898，SCI |
| 20 |
Nguyen Thi Hong Hanh(Nguyen Thi Hong Hanh)、(Linh K. Duong)、(Son T. Nguyen)、(Quy Trinh)、(Hao T. L. Hoang)、(Toan Q. Phung)、林香汶(Hsiang-Wen Lin)、(Huong T.L. Nguyen)*，Quality of Life and Its Associated Factors Among Cancer Patients Receiving Chemotherapy at Oncology Hospitals in Vietnam After the Third Wave of the COVID-19 Pandemic，Cancer Management and Research，2022 Aug，14():2429`-2444，SCI |
| 21 |
吳坤璋(Wu, Kun-Chang)、朱伯振(Chu, Po-Chen)、鄭宇容(Cheng, Yu-Jung)、李佳霙(Chia-Ing Li)、(Jing-Kui Tian)、(Hsing-Yu Wu)、(Szu-Hsien Wu)、(Yi-Chun Lai)、高湘涵(Hsiang-Han Kao)、(Ao-Lin Hsu)、林香汶(Hsiang-Wen Lin)*、林志學(Chih-Hsueh Lin)*，Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia，Journal of Cachexia Sarcopenia and Muscle，2022 Aug，13(4):2073-2087，SCI |
| 22 |
(Zhihao Yang)、(Fredrick Dermawan)、(Asrul Akmal Shafie)、(Ataru Igarashi)、(Eliza Lai?Yi Wong)、(Hilton Lam)、(Hoang Van Minh)、林香汶(Hsiang-Wen Lin)、(Jeonghoon Ahn)、(Juntana Pattanaphesaj)、(Min?Woo Jo)、(Vu Quynh Mai)、(Jan Busschbach)、(Nan Luo)、(Jie Jiang)*，Do health preferences differ among Asian populations? A comparison of EQ‑5D‑5L discrete choice experiments data from 11 Asian studies，QUALITY OF LIFE RESEARCH，2022 Feb，2022():，SCI |
| 23 |
黄怡萍(Huang, Yi-Ping)、林香汶(Hsiang-Wen Lin)、梁文敏(Liang Wen-Miin)、鄭雅興(Cheng， YaHsin)*，引導式自我解釋學習策略對非證照學系學生生理學學習成效的影響，教育實踐與研究/Journal of Educational Practice and Research，2022 Jan，2(2):1-25，TSSCI |
| 24 |
Okti Ratna Mafruhah(Okti Ratna Mafruhah)、黃彥銘(Yen-Ming Huang)、(Olayinka O. Shiyanbola)、沈冠霖(SHEN GUAN-LIN)、林香汶(Hsiang-Wen Lin)*，Ideal instruments used to measure health literacy related to medication use: A systematic review，Research in Social & Administrative Pharmacy，2021 Oct，17(10):1663-1672，SSCI |
| 25 |
江羽柔(Yu-Rou Jiang)、林玟玲(Wen-Ling Lin)*、林香汶(Hsiang-Wen Lin)、陳育傑(Yu-Chieh Chen)、謝右文(Yow-Wen Hsieh)，腦室內抗生素治療腦膜炎、腦室炎之案例系列研究，Formosa Journal of Clinical Pharmacy，2021 Apr，29(2):83-92，Other |
| 26 |
Cao Thi Bich Thao(Cao Thi Bich Thao)、吳坤璋(Wu, Kun-Chang)、徐婕琳(Hsu, Jye-Lin)、張誌祥(Chih-Shiang Chang)、周家弘(Chiahung Chou)、林振源(Lin, Chen-Yuan)、廖裕民(Yu-Min Liao)、林姵君(Lin,Pei-Chun)、楊良友(Liang-Yo Yang)、林香汶(Hsiang-Wen Lin)*，Effects of non-insulin anti-hyperglycemic agents on gut microbiota: A systematic review on human and animal studies，Frontiers in Endocrinology，2020 Sep，11(573891):，SCI |
| 27 |
林香汶(Hsiang-Wen Lin)、張雅惠、戈鈺、王春玉、汪郁珊(Wang, Yu-Shan)、Okti Ratna Mafruhah(Okti Ratna Mafruhah)、吳尚樺、陳育傑(Yu-Chieh Chen)、黃彥銘(Yen-Ming Huang)*，Conceptualization, Development and Psychometric Evaluations of a New Medication-Related Health Literacy Instrument: The Chinese Medication Literacy Measurement，International Journal of Environmental Research and Public Health，2020 Sep，17(19):6951，SCI |
| 28 |
(Nancy L. Shapiro)*、林香汶(Hsiang-Wen Lin)、(Alan Lau)，Creation and delivery of a clinical pharmacy practice and education program for international participants in the United States，Journal of the American College of Clinical Pharmacy，2020 Jun，3():913-919，Other |
| 29 |
林香汶(Hsiang-Wen Lin)、楊琳鈞(YANG LIN-JUN)、Okti Ratna Mafruhah(Okti Ratna Mafruhah)、Nguyen Thi Hong Hanh(Nguyen Thi Hong Hanh)、Cao Thi Bich Thao(Cao Thi Bich Thao)、(Felix K. Yam)*，Evolution of Clinical Pharmacy Practice and Pharmacy Education in Taiwan, Vietnam and Indonesia: A Narrative Review，Journal of the American College of Clinical Pharmacy，2020 May，3():947-958，Other |
| 30 |
姚淑惠(Shu Hui Yao)、蔡相德、林玟玲(Wen-Ling Lin)、陳育傑(Yu-Chieh Chen)、周家弘(Chiahung Chou)、林香汶(Hsiang-Wen Lin)*，Predicting the serum digoxin concentrations of infants in the neonatal intensive care unit through an artificial neural network，BMC Pediatrics，2019 Dec，19(517):，SCI |
| 31 |
林香汶(Hsiang-Wen Lin)*、賴況潔、林志學(Chih-Hsueh Lin)，老人潛在不適當用藥之文獻回顧，長期照護雜誌，2019 Oct，23(2):95-110，Other |
| 32 |
林香汶(Hsiang-Wen Lin)、李佳霙(Chia-Ing Li)、林芳如(Fang- Ju Lin)、張人予(Jen-Yu Chang, MSc)、高純琇(Churn-Shiouh Gau)、(Nan Luo)、(A. Simon Pickard)、(Juan M. Romos Goni)、湯澡薰(Chao-Hsiun Tang)、許茜甯(Chien-Ning Hsu)*，Valuation of the EQ-5D-5L in Taiwan，PLoS One，2018 Dec，13(12):e0209344，SCI |
| 33 |
李志恒*、馮齡儀、李冠漢、李水盛、吳介信、黃耀斌、譚延輝、黃旭山、林香汶(Hsiang-Wen Lin)、方逸萍，藥學教育的核心議題與未來 我國藥學教育改革之探討(三)，藥學雜誌，2018 Dec，34(4):149-157，Other |
| 34 |
林香汶(Margaret Hsiang-Wen Lin)*、林志學(Chih-Hsueh Lin)、張欽凱(Chin-Kan Chang)、周哲毅(Che-Yi Chou)、于怡文、林正介(Cheng-Chieh Lin)、李采娟(Tsai-Chung Li)、李佳霙(Chia-Ing Li)、謝右文(Yow-Wen Hsieh)，Economic Outcomes of Pharmacist-Physician Medication Therapy Management for Polypharmacy Elderly: A Prospective, Randomized, Controlled Trial，JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION，2018 Mar，117(3):235-243，SCI |
| 35 |
許茜甯、林香汶(Lin, Margaret Hsiang-Wen)、Alan Simon(Alan Simon Pickard)、(You-Lin Tain)，EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney disease，INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE，2018 Jan，():，SCI |
| 36 |
(YIng-Chih Yeh)、林香汶(Margaret Hsiang-Wen Lin)、(Elizabeth H. Chang)、(Yen-Ming Huang)、陳育傑(Jack Yu-Chieh Chen)、(Chun-Yu Wang)、(Jen-Wei Liu)、(Yu Ko)*，Development and validation of a Chinese medication literacy measure，HEALTH EXPECTATIONS，2017 Dec，20(6):1269-1301，SCI |
| 37 |
蔡馨慧(Hsin-Hui Tsai)、林香汶(Lin, Margaret Hsiang-Wen)*、蔡邱轔(Chiu-Lin Tsai)、(Felix K. Yam)、林聖興(Lin, Sheng-Shing)，Uncertain Associations of Major Bleeding and Concurrent Use of Antiplatelet Agents and Chinese Medications: A Nested Case-Crossover Study，Evidence-based Complementary and Alternative Medicine，2017 Aug，9417186():，SCI |
| 38 |
林香汶(Margaret Hsiang-Wen Lin)*、(Cory A. Simonavice)、盧炯睿(Chiung-Ray Lu)*、林玟玲(Wen-Ling Lin)、吳博倫(Po-Lun Wu)、周哲毅(Che-Yi Chou)、廖俊惠(Chun-Hui Liao)、藍先元(Hsien-Yuan Lane)，Severe Hypertriglyceridemia Secondary to Venlafaxine Use in an older adult on dialysis case report，BMC HEALTH SERVICES RESEARCH，2017 Apr，17(1):272，SCI |
| 39 |
林香汶(Margaret Hsiang-Wen Lin)、陳育傑(Jack Yu-Chieh Chen)、謝右文(Yow-Wen Hsieh)、蔡輝彥(Huei-Yann Tsai)，優質化老人用藥及藥事照護服務，臺灣臨床藥學雜誌，2016 Nov，24(4):267-281，Other |
| 40 |
(Simon A. Pickard)*、(Ruixuan Jiang)、林香汶(Margaret Hsiang-Wen Lin)、(Sarah Rosenbloom)、(David Cella)，Using PROs to compare relative burden of cancer: EQ-5D and FACT-G in eleven types of cancer，CLINICAL THERAPEUTICS，2016 Apr，38(4):769-777，SCI |
| 41 |
(Francis I. Achike)、(Meng-Chih Lee)、林香汶(Margaret Hsiang-Wen Lin)、周致丞(Fremen Chihchen Chou)、辛幸珍(Hsin-Chen Hsin)、關超然(Chiu-Yin Kwan)，Promoting Interprofessional Education (IPE) with PBL through the Biennial Asia-Pacific Joint Conference on PBL (APJC-PBL)，Journal of Medical Education，2015 Dec，19(4):153-162，Other |
| 42 |
(Felix K. Yam)*、(Lew Tiffany)、(Satish A. Eraly)、林香汶(Margaret Hsiang-Wen Lin)、(Jan D. Hirsch)、(Michelle Devor)，Changes in medication regimen complexity and the risk for 90-day hospital readmission and/or emergency department visits in U.S. Veterans with heart failure，Research in Social & Administrative Pharmacy，2015 Oct，():，SSCI |
| 43 |
程味兒(Wei-Erh Cheng)、蘇莉婷(Li-Ting Su)、陳碩爵(Shuo-Chueh Chen)、李采娟(Tsai-Chung Li)、林香汶(Margaret Hsiang-Wen Lin)*，Economic burden of diabetes mellitus on respiratory failure patients requiring mechanical ventilation during hospitalizations，Value in Health Regional Issues，2014 May，*(3):33-38，Other |
| 44 |
林香汶(Margaret Hsiang-Wen Lin)*、蔡馨慧、于怡文、(Arun Kumar)、伍曼濱，Would It Matter to Expose Elderly Patients Who Took Digoxin to Chinese Medications?，Value in Health Regional Issues，2014 May，(3C):211-221，Other |
| 45 |
蔡馨慧(TSAI HSINHUI)、林香汶(Margaret Hsiang-Wen Lin)*、呂英鴻(Lu YH)、陳怡綾(Chen YL)、(Mahady GB)，A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines，PLoS One，2013 May，8(5):e64255-e64255，SCI |
| 46 |
林香汶(Margaret Hsiang-Wen Lin)*，從民眾及藥師對藥學教育及訓練的期待反思台灣藥學教、考、訓、用之配合，國家菁英季刊，2013 Apr，9(1):71-105，Other |
| 47 |
蔡馨慧(TSAI HSINHUI)、林香汶(Margaret Hsiang-Wen Lin)*、(A. Simon Pickard)、蔡輝彥(Huei-Yann Tsai)、(G. B. Mahady)，Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review，INTERNATIONAL JOURNAL OF CLINICAL PRACTICE，2012 Nov，66(11):1056-1078，SCI |
| 48 |
簡君儒(Chun-Ru Chien)、蘇珊玉(Shan-Yu Su)、(Lorenzo Cohen)、林香汶(Margaret Hsiang-Wen Lin)、(Richard Tsong Lee)、(Ya-Chen Tina Shih)*，Use of Chinese Medicine Among Survivors of Nasopharyngeal Carcinoma in Taiwan: A Population-Based Study，INTEGRATIVE CANCER THERAPIES，2012 Sep，11(3):221-231，SCI |
| 49 |
蔡馨慧(TSAI HSINHUI)、林香汶(Margaret Hsiang-Wen Lin)*、簡君儒(Chun-Ru Chien)、李采娟(Tsai-Chung Li)，Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: a population-based cohort study，EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY，2012 Aug，():，SCI |
| 50 |
魏長菁(Chang-Ching Wei)、于怡文、林香汶(Margaret Hsiang-Wen Lin)*、(Tsai, AC.)*，Occurrence of infection among children with nephrotic syndrome during hospitalizations，NEPHROLOGY，2012 Aug，17():681-688，SCI |
| 51 |
林香汶(Margaret Hsiang-Wen Lin)*、辜鐘慧(Chung-Hui Ku)、李瑞芬(Jui-Fen Li)、陳安琪(An Chee Tan)、周家弘(Chia-Hung Chou)，A nationwide evaluation on electronic medication-related information provided by hospital websites，JOURNAL OF EVALUATION IN CLINICAL PRACTICE，2012 Feb，():，SCI |
| 52 |
簡君儒(Chun-Ru Chien)、林香汶(Margaret Hsiang-Wen Lin)、(Yang, C.-H)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、郭于誠(Yu-Cheng, Kuo)、陳尚文(Shang-Wen Chen)*、梁基安(Ji-An Liang)*，High case volume of radiation oncologists is associated with better survival of nasopharyngeal carcinoma patients treated with radiotherapy: a multifactorial cohort analysis，CLINICAL OTOLARYNGOLOGY，2011 Dec，36(1):558-565，SCI |
| 53 |
林香汶(Margaret Hsiang-Wen Lin)、(A. Simon Pickard)、(Gail B. Mahady)、(George Karabatsos)、(Stephanie Y. Crawford)、(Nicholas G. Popovich)，An Instrument to Evaluate Pharmacists’ Patient Counseling on Herbal and Dietary Supplements，AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION，2010 Dec，74(10):Article192-Article192，SCI |
| 54 |
(A. Simon Pickard)、(James W. Shaw)、林香汶(Margaret Hsiang-Wen Lin)、(Peter C. Trask)、(Neil Aaronson)、(Todd A. Lee)、(David Cella)，A Patient-Based Utility Measure of Health for Clinical Trials of Cancer Therapy Based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire，VALUE IN HEALTH，2009 Apr，12(6):977-988，SCI |
| 55 |
(Pickard AS)、林香汶(Margaret Hsiang-Wen Lin)、(Knight SL)、Sharifi R、(Wu Z)、(Hung SY)、(Witt WP)、張志宏(Chih-Hung Chang)、(Bennett CL)，Proxy assessment of health-related quality of life in African American and White respondents with prostate cancer: perspective matters，MEDICAL CARE，2009 Feb，47(2):176-183，SCI |
| 56 |
陳緋娜(Fei-Na Chen)、李珮端(Pei Dawn Lee Chao)、謝慶良(Ching-Liang Hsieh)、林正介(Cheng-Chieh Lin)、江秀梅、林香汶(Margaret Hsiang-Wen Lin)、朱和翔(Ho-Hsiang Chu)、蔡文正(Tsai, Wen-Chen)、侯鈺琪(Hou YuChi)、洪寶蓮(HUNG,BAO-LIEN)*，台灣中部民眾就醫及用藥概況調查—以某醫學中心門診病患為例，中西整合醫學雜誌，2008 Dec，10(2):1-14，Other |
| 57 |
林香汶(Margaret Hsiang-Wen Lin)、(A. Simon Pickard)*、(Mahady B. Gail)、(Nicholas G. Popovich)，Conceptual development of a measure to assess pharmacists' knowledge of herbal and dietary supplements，AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION，2008 ，72(3):Article 59-article 59，SCI |
| 58 |
(A. Simon Pickard)、(Caitlyn Wilke)、林香汶(Margaret Hsiang-Wen Lin)、(Andrew Lloyd)，Health Utilities Using the EQ-5D in Studies of Cancer，PHARMACOECONOMICS，2007 ，25(5):365-384，SCI |
| 59 |
林香汶(Margaret Hsiang-Wen Lin)*、(Kathy Phan)、(Swu-Jane Lin)，Trends in off-label beta-blocker Use.A Secondary Data Analysis，CLINICAL THERAPEUTICS，2006 ，28(10):1736-1746，SCI |